Considerations for Biologic Product Drug–Drug Interactions: A Regulatory Perspective
2019 ◽
Vol 105
(6)
◽
pp. 1332-1334
◽
2008 ◽
Vol 3
(3)
◽
pp. 325-329
◽
Keyword(s):
Keyword(s):